Coronary artery calcium scores indicating secondary prevention level risk: Findings from the CAC consortium and

Omar Dzaye1, Alexander C Razavi2, Erin D Michos3

  • 1Johns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Atherosclerosis
|February 24, 2022
PubMed

Insights

High coronary artery calcium (CAC) scores in primary prevention patients can indicate atherosclerotic cardiovascular disease (ASCVD) mortality risks similar to secondary prevention patients. This suggests a risk continuum between these groups.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Epidemiology

Background:

  • Coronary artery calcium (CAC) scoring is associated with atherosclerotic cardiovascular disease (ASCVD) risk.
  • The FOURIER trial provided data on ASCVD mortality in a secondary prevention cohort.

Purpose of the Study:

  • To determine CAC scores in primary prevention patients equivalent to ASCVD mortality rates observed in the FOURIER trial.
  • To explore the risk continuum between primary and secondary prevention patients.

Main Methods:

  • Analysis of 20,207 participants from the CAC Consortium aged ≥50 with a 10-year ASCVD risk ≥7.5%.
  • Utilized Poisson regression to model the relationship between CAC and annual ASCVD mortality.
  • Derived equivalent CAC scores based on observed ASCVD mortality rates in FOURIER placebo participants.

Main Results:

  • An annualized ASCVD mortality rate of 0.766 per 100 person-years in FOURIER corresponded to a CAC score of 781 (418-1467).
  • A CAC score of 255 (162-394) matched the ASCVD mortality rate of the lowest-risk FOURIER subgroup.
  • No CAC score replicated the risk of high-risk FOURIER subgroups (e.g., symptomatic PAD, multivessel CAD).

Conclusions:

  • Elevated CAC burden in primary prevention may confer ASCVD mortality risks comparable to stable secondary prevention.
  • Findings support a continuous spectrum of ASCVD risk overlapping between higher-risk primary prevention and stable secondary prevention populations.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
146
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
142
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
36
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
200
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
54
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
59